117 related articles for article (PubMed ID: 35034596)
41. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
[TBL] [Abstract][Full Text] [Related]
42. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
43. Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines.
Özgür A; Kara A; Gökşen Tosun N; Tekin Ş; Gökçe İ
Mol Biol Rep; 2021 Apr; 48(4):3439-3449. PubMed ID: 33999319
[TBL] [Abstract][Full Text] [Related]
44. Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB).
Ma Q; Gao Y; Xu P; Li K; Xu X; Gao J; Qi Y; Xu J; Yang Y; Song W; He X; Liu S; Yuan X; Yin W; He Y; Pan W; Wei L; Zhang J
Biomed Res Int; 2019; 2019():3235021. PubMed ID: 31011573
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.
Jin Q; Mao X; Li B; Guan S; Yao F; Jin F
Tumour Biol; 2015 Mar; 36(3):1895-902. PubMed ID: 25377162
[TBL] [Abstract][Full Text] [Related]
46. LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP).
Cao W; Liu X; Su W; Liang H; Tang H; Zhang W; Huang S; Dang N; Qiao A
Bioengineered; 2022 Feb; 13(2):4573-4586. PubMed ID: 35152838
[TBL] [Abstract][Full Text] [Related]
47. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
48. miR‑28‑5p inhibits the migration of breast cancer by regulating WSB2.
Ma L; Zhang Y; Hu F
Int J Mol Med; 2020 Oct; 46(4):1562-1570. PubMed ID: 32945370
[TBL] [Abstract][Full Text] [Related]
49. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
[TBL] [Abstract][Full Text] [Related]
51. MiR-202 inhibits cell proliferation, invasion, and migration in breast cancer by targeting ROCK1 gene.
Xu F; Li H; Hu C
J Cell Biochem; 2019 Sep; 120(9):16008-16018. PubMed ID: 31106468
[TBL] [Abstract][Full Text] [Related]
52. [Experimental study on inhibitory effect of wogonin on proliferation and invasion of breast cancer cells].
Huang KF; Zhuang Y; Huang YQ; Diao Y
Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1485-9. PubMed ID: 25039187
[TBL] [Abstract][Full Text] [Related]
53. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
Li W; Yi J; Zheng X; Liu S; Fu W; Ren L; Li L; Hoon DSB; Wang J; Du G
Clin Epigenetics; 2018; 10():64. PubMed ID: 29796115
[TBL] [Abstract][Full Text] [Related]
54. Cimicifuga dahurica extract inhibits the proliferation, migration and invasion of breast cancer cells MDA-MB-231 and MCF-7 in vitro and in vivo.
Jia H; Wang X; Liu W; Qin X; Hu B; Ma Q; Lv C; Lu J
J Ethnopharmacol; 2021 Sep; 277():114057. PubMed ID: 33771643
[TBL] [Abstract][Full Text] [Related]
55. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.
Liu H; Wang L; Wang X; Cao Z; Yang Q; Zhang K
World J Surg Oncol; 2013 Apr; 11():93. PubMed ID: 23618129
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes.
Zhu Y; Wang Q; Xia Y; Xiong X; Weng S; Ni H; Ye Y; Chen L; Lin J; Chen Y; Niu H; Chen X; Lin Y
BMC Cancer; 2020 Jul; 20(1):644. PubMed ID: 32650755
[TBL] [Abstract][Full Text] [Related]
57. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
[TBL] [Abstract][Full Text] [Related]
58. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
59. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
[TBL] [Abstract][Full Text] [Related]
60. NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis.
Yoon SH; Kim HS; Kim RN; Jung SY; Hong BS; Kang EJ; Lee HB; Moon HG; Noh DY; Han W
BMC Cancer; 2020 May; 20(1):375. PubMed ID: 32366230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]